U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Mixture
Created
by admin
on Mon Mar 31 19:46:55 GMT 2025
Edited
by admin
on Mon Mar 31 19:46:55 GMT 2025
Record UNII
4U3D3YY81M
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Teicoplanin
INN   MART.   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
TAGOCID
Preferred Name English
TEIKOPLANIN
Common Name English
TEICHOMYCIN A2
Common Name English
teicoplanin [INN]
Common Name English
TARGOCID
Brand Name English
MDL 507
Code English
Teicoplanin [WHO-DD]
Common Name English
NSC-759183
Code English
TEICOPLANIN [EP MONOGRAPH]
Common Name English
TARGOSID
Brand Name English
TEICOPLANIN [MART.]
Common Name English
TEICOPLANIN A2
Common Name English
TEICOPLANIN [VANDF]
Common Name English
MDL-507
Code English
TEICOPLANIN [USAN]
Common Name English
TEICOPLANIN [JAN]
Common Name English
TICOCIN
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C61101
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
WHO-ATC J01XA02
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
EU-Orphan Drug EU/3/17/1913
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
FDA ORPHAN DRUG 631418
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
WHO-VATC QJ01XA02
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
Code System Code Type Description
DRUG CENTRAL
2998
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
PRIMARY
WIKIPEDIA
TEICOPLANIN
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
PRIMARY
RXCUI
57021
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
PRIMARY RxNorm
CHEBI
29687
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
PRIMARY
ChEMBL
CHEMBL2367892
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
PRIMARY
LACTMED
Teicoplanin
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
PRIMARY
CAS
61036-62-2
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
PRIMARY
EPA CompTox
DTXSID4048642
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
PRIMARY
EVMPD
SUB129950
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
PRIMARY
USAN
X-16
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
PRIMARY
DRUG BANK
DB06149
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
PRIMARY
SMS_ID
100000085403
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
PRIMARY
EVMPD
SUB04714MIG
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
PRIMARY
INN
5155
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
PRIMARY
NCI_THESAURUS
C1412
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
PRIMARY
MESH
D017334
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
PRIMARY
FDA UNII
4U3D3YY81M
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
PRIMARY
NSC
759183
Created by admin on Mon Mar 31 19:46:55 GMT 2025 , Edited by admin on Mon Mar 31 19:46:55 GMT 2025
PRIMARY
All of the following components must be present:
Structure of TEICOPLANIN A2-5
Structure of TEICOPLANIN A2-4
Structure of Teicoplanin A2-1a
Structure of TEICOPLANIN A2-1
Structure of TEICOPLANIN A2-2
Structure of TEICOPLANIN A2-3
Structure of TEICOPLANIN A3-1
Structure of Teicoplanin A2-1b
Related Record Type Details
PLASMA PROTEIN FRACTION (HUMAN)
BINDER->LIGAND
BINDING
Teicoplanin
EXCRETED UNCHANGED
IV or IM route of admininstration.
URINE
Related Record Type Details
Structure of Mesityl oxide
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
Teicoplanin
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
Definition References
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966